LE SURDOSAGE ET ACCIDENTS AUX AVK : ETUDE CAS TEMOIN : A PROPOS DE 400 PATIENTS
- Service de cardiologie CHU Mohammed VI Marrakech.
- Abstract
- Keywords
- References
- Cite This Article as
- Corresponding Author
Introduction: occurrence of bleeding is the most feared complication of warfarin and prevention remains a key concern in monitoring. The purpose of this study is to identify the characteristics of patients with severe accidents AVK and its management. Material and Methods: We conducted a prospective study of 100 patients conducted in the cardiology department chu Mohamed VI in Marrakech from Mai 2014 to Mai 2016. Résultat: The average age of our patients is 55 sex ratio of 1, 27. Atrial fibrillation was the main indication identified. Gastrointestinal bleeding origin was the most frequent in 60% of cases. The majority of patients experienced at least one bleeding risk factor: age in 30% of cases, the biological overdose of INR 80% of cases, drug interactions in 10% of cases of hypertension in 40 % of cases, cerebrovascular diseases in 13% of cases and the antecedent of bleeding in 10%. 60% of our patients did not have a good biological monitoring based INR default means. The emergency conduct was based on the cessation of AVK, the administration saw K, transfusion of packed red cells and fresh frozen plasma. The average hospital stay is 2 days Conclusion: The prognosis The AVK is one of the most effective treatments. However, their handling is difficult and the risk of bleeding complications is present. The new oral anticoagulants offer another alternative.
- RA O’ Reilly. Piccin. 2000. Pharmacologie fondamentale et clinique (7 éme édition) pp. 570–4. Médicaments utilisés dans les troubles de la coagulation
- Agence francaise de sécurité sanitaire des produits de santé (AFSSAPS); 2001. Janvier
- 2000. Pharmacologie fondamentale et clinique (7 éme édition) pp. 570–4. Médicaments utilisés dans les troubles de la coagulation
- Gitter MJ, Jaeger TM, Petterson TM, Gersh BJ, Silverstein MD. Bleeding and thromboembolism during anticoagulant therapy: A population-based study in Rochester Minnsota. Mayo Clin Proc 1995;70:725—33.
- Launbjerg J, Egeblad H, Heaf J, et al. Bleeding complications to oral anticoagulation therapy: Multivariate analysis of 1010 treatment years in 551 outpatients. J Intern Med 1991;229:351—5.
- The stroke prevention in atrial fibrillation investigators. Bleeding during anti-thrombotic therapy in patients with atrial fibrillation. Arch Intern Med 1996;156:409—16.
- Penning-van Beest FJ, Van Meegen E, Rosendaal FR, et al. Characteristics of anticoagulant therapy and comorbidity related to over anticoagulation. Thromb Haemost 2001;86:569—74.
- Levine MN, Raskob G, Landefeld S, Kearon C. Hemorrhagic complications of anticoagulant treatment. Chest 2001;119:108S—21S.
- Fihn SD, Callanhan CM, Martin DC, McDonell MB, Henikoff JG, White RH. The risk for and severity of bleeding complications in elderly patients treated with warfarin. The National consortium of anticoagulation clinics. Ann Intern Med 1996;124:970—9.
- Siguret V, Esquirol C, Debray M, Gouin I, Andreux JP, Pautas E. Surdosage en antivitamine K dans une population de patients hospitalisés âgés de plus de 70 ans : enquête prospective sur un an. Presse Med 2003;32:972—7.
- Tremey B, Tazarourte K, Ract C, Gabteni M, Lavagna L, Dépret-Vassal J, et al. Teaching improves adherence to clinical guidelines in the treatment of oral anticoagulation related severe bleeding in the Emergency Department. ESICM J 2009;35:1444-8. 12-Suzuki M, et al. Improvement of HAS-BLED bleeding scores predictive capability by changing the definition of renal dysfunction in Japanese atrial fibrillation patients on anticoagulation therapy. J Cardiol 2014;876:421-510.
- Boston Area anticoagulation Trial for Atrial Fibrillation Investigators. The effect of low dose warfarin on the risk of stroke in patients with non-rheumatic atrial fibrillation. N Engl J Med 1990; 323:1505-11.
[ M. Ztati, S. Elkarimi and M.EL Hattaoui (2017); LE SURDOSAGE ET ACCIDENTS AUX AVK : ETUDE CAS TEMOIN : A PROPOS DE 400 PATIENTS Int. J. of Adv. Res. 5 (Jan). 1841-1845] (ISSN 2320-5407). www.journalijar.com
Cardiologie